🔬Deep Research

POM — Pomdoctor Ltd ADR · catalysts, narrative & risks

·19 sourcesPOM forecast →

POMDOCTOR LIMITED (Nasdaq: POM) — Research Note as of 2026-10-30

PomDoctor Limited is a Guangzhou, China–based foreign private issuer operating an online pharmaceutical retail portal and a chronic-disease internet-hospital platform in China, with a stated strategic pivot toward AI-enabled "predictive healthcare" [1], [2], [17], [20]. Historically it listed via an unsponsored ADR structure (ADS ticker POM); as noted below, it is in the process of ending that structure. All figures below are point-in-time snapshots from third-party providers and conflict materially across sources — see the "data reliability" note.

Key Recent Catalysts (last ~1–3 months)


AI-assisted research from the K3vl4r desk — not personalized investment advice. More research →